EP Patent

EP0832897A2 — Hydrated zirconium silicate composition for purification of nucleic acids

Assigned to Becton Dickinson and Co · Expires 1998-04-01 · 28y expired

What this patent protects

The present invention relates to a unique hydrated zirconium silicate composition which binds nucleic acids. The composition is useful in processes for purifying nucleic acid from a sample.

USPTO Abstract

The present invention relates to a unique hydrated zirconium silicate composition which binds nucleic acids. The composition is useful in processes for purifying nucleic acid from a sample.

Drugs covered by this patent

sodium-zirconium-cyclosilicate (SODIUM ZIRCONIUM CYCLOSILICATE)

Patent Metadata

Patent number: EP0832897A2
Jurisdiction: EP
Classification: —
Expires: 1998-04-01
Drug substance claim: No
Drug product claim: No
Assignee: Becton Dickinson and Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.